US 11168083
Inhibitors of Plasma Kallikrein and uses thereof
granted A61PA61P7/10
Quick answer
US patent 11168083 (Inhibitors of Plasma Kallikrein and uses thereof) held by Takeda Pharmaceutical Company Limited expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P7/10